Phase 2b is completed.
Samumed is in Phase 3 too:
A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
https://clinicaltrials.gov/ct2/show/NCT03742518?term=samumed
Dear Friends and Colleagues,
On behalf of the Program Committee, we are pleased to invite you to the 11th World Congress for Hair Research to take place in 2019 in Sitges (Barcelona)
Continuing the tradition set by the International Hair Research Societies, the Congress will be a...